Santhera Pharmaceuticals Holding Ltd

Santhera Pharmaceuticals is a Swiss biopharmaceutical company focusing on the discovery, development and marketing of small molecule pharmaceutical products for the treatment of neuromuscular diseases. Santhera’s vision is to become the leading specialty pharmaceuticals company offering therapies for a number of indications in this area of high unmet medical need which includes many orphan indications with no current therapy. Santhera has a proven track-record in discovering and developing drug candidates that address severe neuromuscular disorders in orphan or even ultra-orphan diseases. Santhera’s drug pipeline comprises a Phase III program in Friedreich's Ataxia, a Phase II program in Duchenne Muscular Dystrophy and three preclinical programs in diabetes, cachexia/anorexia, and Duchenne Muscular Dystrophy.

Contact Details: Hammerstrasse 47 Liestal CH-4410 Switzerland Tel: 41 (0) 61 906 89 50 Fax: 41 (0) 61 906 89 51 Email: office@santhera.com WWW: www.santhera.com/

BioNews Results for Santhera Pharmaceuticals Holding Ltd:
Publication in European Heart Journal highlights potential of Santhera's SNT-MC17/idebenone in Duchenne Muscul	Checkbiotech:  Sep 25 2008 2:58PM Matching: santhera pharmaceuticals holding

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 136 times since April 2007, the link to the organisation's website has been followed 29 times

Recent Search Terms used to find this page: Santhera tel. | .

Search for more companies in Liestal

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Santhera Pharmaceuticals Holding Ltd